Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$39.33 USD
+0.90 (2.34%)
Updated Jul 31, 2024 04:00 PM ET
After-Market: $39.36 +0.03 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BHVN 39.33 +0.90(2.34%)
Will BHVN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BHVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHVN
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
BHVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
Arcellx (ACLX) Up 5% on Partnership Expansion With Gilead
Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?
Other News for BHVN
Biohaven: Taldefgrobep Alfa Might Have A Place Beyond SMA Treatment
Biohaven(BHVN) Shares Cross Above 200 DMA
Tesla downgraded, Spotify upgraded: Wall Street's top analyst calls
Biohaven initiated with bullish view at Morgan Stanley, here's why
Morgan Stanley starts Biohaven at overweight, cites broad pipeline